Kayser–Fleischer ring in Wilson's disease: A cohort study
Abstract Aims To evaluate Wilson's disease (WD) features in Sardinian patients with Kayser–Fleischer (KF) ring and to evaluate correlations between modifications in KF and anti-copper therapy and systemic WD evolution. Patients and methods Sixty-seven WD patients (35 m/32 f; mean age 41 years)...
Gespeichert in:
Veröffentlicht in: | European journal of internal medicine 2012-09, Vol.23 (6), p.e150-e156 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e156 |
---|---|
container_issue | 6 |
container_start_page | e150 |
container_title | European journal of internal medicine |
container_volume | 23 |
creator | Fenu, M Liggi, M Demelia, E Sorbello, O Civolani, A Demelia, L |
description | Abstract Aims To evaluate Wilson's disease (WD) features in Sardinian patients with Kayser–Fleischer (KF) ring and to evaluate correlations between modifications in KF and anti-copper therapy and systemic WD evolution. Patients and methods Sixty-seven WD patients (35 m/32 f; mean age 41 years) were retrospectively studied. At diagnosis and during follow up comprehensive ophthalmologic and neurologic examinations, brain RMN and ECD SPECT, detailed objective laboratory studies and hepatic histological examination were performed on all patients for analysis. All patients were given anti-copper therapy with d -Penicillamine in mono-therapy or in combination with Zinc Salts. Results At diagnosis, KF was observed in 27% of patients with equal distribution in all age groups. Significant correlations between KF at diagnosis, neuro-psychiatric manifestations and pathologic features in brain RMN and in brain ECD SPECT were found at diagnosis. During follow up, a decrease in, or regression of KF was seen in 14% of patients. Anti-copper therapy leads to KF regression and prevents the appearance of KF. No significant correlations were observed between KF regression and clinical neurological or neuro-imaging improvement nor between KF modifications and clinical hepatic improvement. Conclusions Our study highlights the peculiar features of Sardinian WD patients: low representation of KF, its equal distribution in all age groups, significant correlation between KF at diagnosis and clinical neurological manifestations, pathologic brain RMN and brain ECD-SPECT are highlighted by our study. Anti-copper therapy induces KF regression and prevents its onset. Therefore, KF ring does appear to be a predictive factor in the neurological and hepatic evolution of WD. |
doi_str_mv | 10.1016/j.ejim.2012.04.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1032611062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0953620512000921</els_id><sourcerecordid>1032611062</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-bdbedcfe6affa898d5bc68714838e8ac94910bb23da967f2c1929fe6cb1a182b3</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhi1E1S6lL8AB5QaXpDNONmsDQqqqllZU4gCIo-XYE-qQTYonQdob78Ab9klwtIUDB05z-f5fM98I8QyhQMD6tCuoC9tCAsoCqgJg_UisUG10Dkqqx2IFel3mtYT1kXjC3AHgBqA8FEdSqrqsKlyJ1-_tjine__x12VNgd0sxi2H4moUh-xJ6HocXnPnAZJleZWeZG2_HOGU8zX73VBy0tmc6eZjH4vPlxafzq_zmw7vr87Ob3FWIU974hrxrqbZta5VWft24Wm2wUqUiZZ2uNELTyNJbXW9a6VBLnXDXoEUlm_JYvNz33sXx-0w8mW3alPreDjTObBBKWSNCLRMq96iLI3Ok1tzFsLVxlyCzSDOdWaSZRZqByiRpKfT8oX9utuT_Rv5YSsCbPUDpyh-BomEXaHDkQyQ3GT-G__e__Sfu-jAEZ_tvtCPuxjkOyZ9BwyljPi5vW76GEgC0xPI3iiSSyg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1032611062</pqid></control><display><type>article</type><title>Kayser–Fleischer ring in Wilson's disease: A cohort study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Fenu, M ; Liggi, M ; Demelia, E ; Sorbello, O ; Civolani, A ; Demelia, L</creator><creatorcontrib>Fenu, M ; Liggi, M ; Demelia, E ; Sorbello, O ; Civolani, A ; Demelia, L</creatorcontrib><description>Abstract Aims To evaluate Wilson's disease (WD) features in Sardinian patients with Kayser–Fleischer (KF) ring and to evaluate correlations between modifications in KF and anti-copper therapy and systemic WD evolution. Patients and methods Sixty-seven WD patients (35 m/32 f; mean age 41 years) were retrospectively studied. At diagnosis and during follow up comprehensive ophthalmologic and neurologic examinations, brain RMN and ECD SPECT, detailed objective laboratory studies and hepatic histological examination were performed on all patients for analysis. All patients were given anti-copper therapy with d -Penicillamine in mono-therapy or in combination with Zinc Salts. Results At diagnosis, KF was observed in 27% of patients with equal distribution in all age groups. Significant correlations between KF at diagnosis, neuro-psychiatric manifestations and pathologic features in brain RMN and in brain ECD SPECT were found at diagnosis. During follow up, a decrease in, or regression of KF was seen in 14% of patients. Anti-copper therapy leads to KF regression and prevents the appearance of KF. No significant correlations were observed between KF regression and clinical neurological or neuro-imaging improvement nor between KF modifications and clinical hepatic improvement. Conclusions Our study highlights the peculiar features of Sardinian WD patients: low representation of KF, its equal distribution in all age groups, significant correlation between KF at diagnosis and clinical neurological manifestations, pathologic brain RMN and brain ECD-SPECT are highlighted by our study. Anti-copper therapy induces KF regression and prevents its onset. Therefore, KF ring does appear to be a predictive factor in the neurological and hepatic evolution of WD.</description><identifier>ISSN: 0953-6205</identifier><identifier>EISSN: 1879-0828</identifier><identifier>DOI: 10.1016/j.ejim.2012.04.005</identifier><identifier>PMID: 22863441</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adolescent ; Adult ; Brain - diagnostic imaging ; Brain - pathology ; Chelating Agents - therapeutic use ; Cohort Studies ; Disease Progression ; Female ; Hepatolenticular Degeneration - drug therapy ; Hepatolenticular Degeneration - pathology ; Hepatolenticular Degeneration - physiopathology ; Humans ; Internal Medicine ; Italy ; Kayser–Fleischer ring ; Limbus Corneae - pathology ; Liver ; Liver - pathology ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neurological involvement ; Outcome ; Penicillamine - therapeutic use ; Retrospective Studies ; Therapy ; Tomography, Emission-Computed, Single-Photon ; Treatment Outcome ; Wilson's disease</subject><ispartof>European journal of internal medicine, 2012-09, Vol.23 (6), p.e150-e156</ispartof><rights>European Federation of Internal Medicine.</rights><rights>2012 European Federation of Internal Medicine.</rights><rights>Copyright © 2012 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-bdbedcfe6affa898d5bc68714838e8ac94910bb23da967f2c1929fe6cb1a182b3</citedby><cites>FETCH-LOGICAL-c411t-bdbedcfe6affa898d5bc68714838e8ac94910bb23da967f2c1929fe6cb1a182b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejim.2012.04.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22863441$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fenu, M</creatorcontrib><creatorcontrib>Liggi, M</creatorcontrib><creatorcontrib>Demelia, E</creatorcontrib><creatorcontrib>Sorbello, O</creatorcontrib><creatorcontrib>Civolani, A</creatorcontrib><creatorcontrib>Demelia, L</creatorcontrib><title>Kayser–Fleischer ring in Wilson's disease: A cohort study</title><title>European journal of internal medicine</title><addtitle>Eur J Intern Med</addtitle><description>Abstract Aims To evaluate Wilson's disease (WD) features in Sardinian patients with Kayser–Fleischer (KF) ring and to evaluate correlations between modifications in KF and anti-copper therapy and systemic WD evolution. Patients and methods Sixty-seven WD patients (35 m/32 f; mean age 41 years) were retrospectively studied. At diagnosis and during follow up comprehensive ophthalmologic and neurologic examinations, brain RMN and ECD SPECT, detailed objective laboratory studies and hepatic histological examination were performed on all patients for analysis. All patients were given anti-copper therapy with d -Penicillamine in mono-therapy or in combination with Zinc Salts. Results At diagnosis, KF was observed in 27% of patients with equal distribution in all age groups. Significant correlations between KF at diagnosis, neuro-psychiatric manifestations and pathologic features in brain RMN and in brain ECD SPECT were found at diagnosis. During follow up, a decrease in, or regression of KF was seen in 14% of patients. Anti-copper therapy leads to KF regression and prevents the appearance of KF. No significant correlations were observed between KF regression and clinical neurological or neuro-imaging improvement nor between KF modifications and clinical hepatic improvement. Conclusions Our study highlights the peculiar features of Sardinian WD patients: low representation of KF, its equal distribution in all age groups, significant correlation between KF at diagnosis and clinical neurological manifestations, pathologic brain RMN and brain ECD-SPECT are highlighted by our study. Anti-copper therapy induces KF regression and prevents its onset. Therefore, KF ring does appear to be a predictive factor in the neurological and hepatic evolution of WD.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - pathology</subject><subject>Chelating Agents - therapeutic use</subject><subject>Cohort Studies</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Hepatolenticular Degeneration - drug therapy</subject><subject>Hepatolenticular Degeneration - pathology</subject><subject>Hepatolenticular Degeneration - physiopathology</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Italy</subject><subject>Kayser–Fleischer ring</subject><subject>Limbus Corneae - pathology</subject><subject>Liver</subject><subject>Liver - pathology</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neurological involvement</subject><subject>Outcome</subject><subject>Penicillamine - therapeutic use</subject><subject>Retrospective Studies</subject><subject>Therapy</subject><subject>Tomography, Emission-Computed, Single-Photon</subject><subject>Treatment Outcome</subject><subject>Wilson's disease</subject><issn>0953-6205</issn><issn>1879-0828</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFu1DAQhi1E1S6lL8AB5QaXpDNONmsDQqqqllZU4gCIo-XYE-qQTYonQdob78Ab9klwtIUDB05z-f5fM98I8QyhQMD6tCuoC9tCAsoCqgJg_UisUG10Dkqqx2IFel3mtYT1kXjC3AHgBqA8FEdSqrqsKlyJ1-_tjine__x12VNgd0sxi2H4moUh-xJ6HocXnPnAZJleZWeZG2_HOGU8zX73VBy0tmc6eZjH4vPlxafzq_zmw7vr87Ob3FWIU974hrxrqbZta5VWft24Wm2wUqUiZZ2uNELTyNJbXW9a6VBLnXDXoEUlm_JYvNz33sXx-0w8mW3alPreDjTObBBKWSNCLRMq96iLI3Ok1tzFsLVxlyCzSDOdWaSZRZqByiRpKfT8oX9utuT_Rv5YSsCbPUDpyh-BomEXaHDkQyQ3GT-G__e__Sfu-jAEZ_tvtCPuxjkOyZ9BwyljPi5vW76GEgC0xPI3iiSSyg</recordid><startdate>20120901</startdate><enddate>20120901</enddate><creator>Fenu, M</creator><creator>Liggi, M</creator><creator>Demelia, E</creator><creator>Sorbello, O</creator><creator>Civolani, A</creator><creator>Demelia, L</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120901</creationdate><title>Kayser–Fleischer ring in Wilson's disease: A cohort study</title><author>Fenu, M ; Liggi, M ; Demelia, E ; Sorbello, O ; Civolani, A ; Demelia, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-bdbedcfe6affa898d5bc68714838e8ac94910bb23da967f2c1929fe6cb1a182b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - pathology</topic><topic>Chelating Agents - therapeutic use</topic><topic>Cohort Studies</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Hepatolenticular Degeneration - drug therapy</topic><topic>Hepatolenticular Degeneration - pathology</topic><topic>Hepatolenticular Degeneration - physiopathology</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Italy</topic><topic>Kayser–Fleischer ring</topic><topic>Limbus Corneae - pathology</topic><topic>Liver</topic><topic>Liver - pathology</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neurological involvement</topic><topic>Outcome</topic><topic>Penicillamine - therapeutic use</topic><topic>Retrospective Studies</topic><topic>Therapy</topic><topic>Tomography, Emission-Computed, Single-Photon</topic><topic>Treatment Outcome</topic><topic>Wilson's disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fenu, M</creatorcontrib><creatorcontrib>Liggi, M</creatorcontrib><creatorcontrib>Demelia, E</creatorcontrib><creatorcontrib>Sorbello, O</creatorcontrib><creatorcontrib>Civolani, A</creatorcontrib><creatorcontrib>Demelia, L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of internal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fenu, M</au><au>Liggi, M</au><au>Demelia, E</au><au>Sorbello, O</au><au>Civolani, A</au><au>Demelia, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kayser–Fleischer ring in Wilson's disease: A cohort study</atitle><jtitle>European journal of internal medicine</jtitle><addtitle>Eur J Intern Med</addtitle><date>2012-09-01</date><risdate>2012</risdate><volume>23</volume><issue>6</issue><spage>e150</spage><epage>e156</epage><pages>e150-e156</pages><issn>0953-6205</issn><eissn>1879-0828</eissn><abstract>Abstract Aims To evaluate Wilson's disease (WD) features in Sardinian patients with Kayser–Fleischer (KF) ring and to evaluate correlations between modifications in KF and anti-copper therapy and systemic WD evolution. Patients and methods Sixty-seven WD patients (35 m/32 f; mean age 41 years) were retrospectively studied. At diagnosis and during follow up comprehensive ophthalmologic and neurologic examinations, brain RMN and ECD SPECT, detailed objective laboratory studies and hepatic histological examination were performed on all patients for analysis. All patients were given anti-copper therapy with d -Penicillamine in mono-therapy or in combination with Zinc Salts. Results At diagnosis, KF was observed in 27% of patients with equal distribution in all age groups. Significant correlations between KF at diagnosis, neuro-psychiatric manifestations and pathologic features in brain RMN and in brain ECD SPECT were found at diagnosis. During follow up, a decrease in, or regression of KF was seen in 14% of patients. Anti-copper therapy leads to KF regression and prevents the appearance of KF. No significant correlations were observed between KF regression and clinical neurological or neuro-imaging improvement nor between KF modifications and clinical hepatic improvement. Conclusions Our study highlights the peculiar features of Sardinian WD patients: low representation of KF, its equal distribution in all age groups, significant correlation between KF at diagnosis and clinical neurological manifestations, pathologic brain RMN and brain ECD-SPECT are highlighted by our study. Anti-copper therapy induces KF regression and prevents its onset. Therefore, KF ring does appear to be a predictive factor in the neurological and hepatic evolution of WD.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>22863441</pmid><doi>10.1016/j.ejim.2012.04.005</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0953-6205 |
ispartof | European journal of internal medicine, 2012-09, Vol.23 (6), p.e150-e156 |
issn | 0953-6205 1879-0828 |
language | eng |
recordid | cdi_proquest_miscellaneous_1032611062 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adolescent Adult Brain - diagnostic imaging Brain - pathology Chelating Agents - therapeutic use Cohort Studies Disease Progression Female Hepatolenticular Degeneration - drug therapy Hepatolenticular Degeneration - pathology Hepatolenticular Degeneration - physiopathology Humans Internal Medicine Italy Kayser–Fleischer ring Limbus Corneae - pathology Liver Liver - pathology Magnetic Resonance Imaging Male Middle Aged Neurological involvement Outcome Penicillamine - therapeutic use Retrospective Studies Therapy Tomography, Emission-Computed, Single-Photon Treatment Outcome Wilson's disease |
title | Kayser–Fleischer ring in Wilson's disease: A cohort study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T07%3A00%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kayser%E2%80%93Fleischer%20ring%20in%20Wilson's%20disease:%20A%20cohort%20study&rft.jtitle=European%20journal%20of%20internal%20medicine&rft.au=Fenu,%20M&rft.date=2012-09-01&rft.volume=23&rft.issue=6&rft.spage=e150&rft.epage=e156&rft.pages=e150-e156&rft.issn=0953-6205&rft.eissn=1879-0828&rft_id=info:doi/10.1016/j.ejim.2012.04.005&rft_dat=%3Cproquest_cross%3E1032611062%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1032611062&rft_id=info:pmid/22863441&rft_els_id=S0953620512000921&rfr_iscdi=true |